Flying eye hospital gets new aeroplane

Article

Orbis International, an international nonprofit humanitarian organization which operates the world"s only Flying Eye Hospital, is to upgrade from a DC-10-10 to a DC-10 Series 30 freighter airline, giving the project an extra 20 years of flying time.

Orbis International, an international nonprofit humanitarian organization which operates the world’s only Flying Eye Hospital, is to upgrade from a DC-10-10 to a DC-10 Series 30 freighter airline, giving the project an extra 20 years of flying time. The donation of the new $2 million freighter by United Airlines and FedEx Corp was announced at this year’s ASCRS congress in Chicago, US.

The first Orbis Flying Eye Hospital became operational in 1982. Since then it has conducted more than 900 sight-saving programmes in 86 countries, treating more than 6.8 million people. The hospital treats conditions including cataract, childhood and corneal blindness, diabetic retinopathy, glaucoma, retinoblastoma, retinopathy of prematurity, strabismus and trachoma, and also performs oculoplastic surgery. Having already visited Myanmar, Viet Nam and Kuwait earlier this year, planned destinations for the rest of 2008 also include Dubai, Iran, Syria, Tanzania, Nigeria, Uganda and China.

As well as the ophthalmic surgical centre - which includes a laser treatment room, an operating theatre, a sterilization room and a recovery room - the aircraft also contains a classroom and audiovisual centre, enabling Orbis to conduct training programmes for local healthcare practitioners. This involves holding lectures, broadcasting live surgeries, and recording videos of procedures to leave with local institutions for further training. Orbis also puts in place structures to assist with human resource and organizational development, infrastructure and technology, community partnership and effective disease control, monitoring and evaluation.

The new Series 30 freighter is approximately ten years younger than Orbis’s current model and is more cost-effective, as replacement parts for the older model are now both expensive and scarce. It is expected to take two years to modify the freighter and fit it with enough equipment to maintain the flying hospital’s state of the art ophthalmic facility. ORBIS Executive Director Geoffrey Holland said, "This is a truly wonderful gift to the world."

 

Read

ASCRS 2008 meeting highlights.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.